26 September 2023
: Case report 
Successful Extracorporeal Cytokine Hemoadsorption in a Marfan Syndrome Patient with COVID-19 Undergoing Redo Bentall Procedure
Management of emergency care
Ajmer Singh1BCE, Chinmaya Nanda1BCE, Yatin Mehta2BE*, Anil Bhan3ADEDOI: 10.12659/AJCR.940383
Am J Case Rep 2023; 24:e940383
Table 1. Course of relevant laboratory and clinical markers in the perioperative period.
| Parameter | Preoperative | POD 1 | POD 2 | POD 3 | POD 5 |
|---|---|---|---|---|---|
| Hemoglobin (mg/dl) | 8.3 | 8.7 | 8.2 | 8.5 | 8.5 |
| Differential leukocyte count | N84 L11 M2 E3 | N85 L7 M6 E2 | N84 L9 M7 E0 | N82 L12 M5 E1 | P79 L12 M5 E3 |
| Platelets (per µL) | 102 000 | 100 000 | 141 000 | 112 000 | 120 000 |
| Lactate (mmol/L) | 2.1 | 6.4 | 1.9 | 1.2 | 1.0 |
| Blood loss (ml) | – | 300 | 50 | – | – |
| Urine output (ml) | – | 830 | 2500 | 2100 | 2200 |
| POD – postoperative day; N – neutrophils; L – lymphocytes; M – monocytes; E – eosinophils. | |||||